Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$30.85 - $37.09 $4,164 - $5,007
-135 Reduced 0.58%
23,191 $825,000
Q3 2023

Nov 14, 2023

SELL
$31.69 - $39.25 $1.75 Million - $2.17 Million
-55,311 Reduced 70.34%
23,326 $781,000
Q2 2023

Aug 14, 2023

BUY
$29.0 - $38.37 $1.15 Million - $1.52 Million
39,641 Added 101.65%
78,637 $2.95 Million
Q1 2023

May 15, 2023

SELL
$23.85 - $31.34 $2.1 Million - $2.76 Million
-87,961 Reduced 69.28%
38,996 $1.14 Million
Q4 2022

Feb 14, 2023

SELL
$17.65 - $27.37 $375,415 - $582,159
-21,270 Reduced 14.35%
126,957 $3.34 Million
Q3 2022

Nov 14, 2022

SELL
$22.62 - $32.54 $893,286 - $1.29 Million
-39,491 Reduced 21.04%
148,227 $3.44 Million
Q2 2022

Aug 15, 2022

BUY
$22.88 - $39.45 $3.53 Million - $6.08 Million
154,150 Added 459.22%
187,718 $4.73 Million
Q1 2022

May 16, 2022

SELL
$31.69 - $43.29 $1.86 Million - $2.55 Million
-58,795 Reduced 63.66%
33,568 $1.28 Million
Q4 2021

Feb 14, 2022

SELL
$35.2 - $52.6 $719,804 - $1.08 Million
-20,449 Reduced 18.13%
92,363 $3.63 Million
Q3 2021

Nov 15, 2021

BUY
$46.35 - $59.75 $3.13 Million - $4.03 Million
67,439 Added 148.63%
112,812 $5.51 Million
Q2 2021

Aug 16, 2021

BUY
$47.2 - $67.81 $2.14 Million - $3.08 Million
45,373 New
45,373 $2.38 Million
Q1 2021

May 17, 2021

SELL
$30.93 - $59.48 $606,228 - $1.17 Million
-19,600 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$18.53 - $31.5 $264,460 - $449,568
-14,272 Reduced 42.14%
19,600 $605,000
Q3 2020

Nov 16, 2020

SELL
$14.68 - $19.12 $2.41 Million - $3.14 Million
-164,441 Reduced 82.92%
33,872 $628,000
Q2 2020

Aug 14, 2020

BUY
$8.5 - $15.82 $1.03 Million - $1.92 Million
121,481 Added 158.11%
198,313 $2.74 Million
Q1 2020

May 15, 2020

SELL
$7.25 - $19.22 $356,330 - $944,643
-49,149 Reduced 39.01%
76,832 $705,000
Q4 2019

Feb 14, 2020

BUY
$13.77 - $19.2 $1.73 Million - $2.42 Million
125,981 New
125,981 $2.19 Million
Q2 2019

Aug 14, 2019

SELL
$15.01 - $18.89 $1.75 Million - $2.2 Million
-116,384 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$16.23 - $20.29 $3.24 Million - $4.05 Million
-199,833 Reduced 63.19%
116,384 $2.04 Million
Q4 2018

Feb 14, 2019

SELL
$10.77 - $18.44 $1.93 Million - $3.31 Million
-179,249 Reduced 36.18%
316,217 $5.5 Million
Q3 2018

Nov 14, 2018

BUY
$9.1 - $14.8 $4.51 Million - $7.33 Million
495,466 New
495,466 $7.01 Million
Q2 2018

Aug 14, 2018

SELL
$9.6 - $14.6 $2.26 Million - $3.44 Million
-235,356 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$5.7 - $12.3 $1.34 Million - $2.89 Million
235,356 New
235,356 $2.34 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.